JMM Profile: Carbapenems: a broad-spectrum antibiotic.

Autor: Armstrong T; School of Chemistry, Biodiscovery Institute, University Park, Nottingham University, Nottingham, NG7 2RD, UK., Fenn SJ; School of Life Sciences and National Biofilm Innovation Centre, Biodiscovery Institute, University Park, Nottingham University, Nottingham, NG7 2RD, UK., Hardie KR; School of Life Sciences and National Biofilm Innovation Centre, Biodiscovery Institute, University Park, Nottingham University, Nottingham, NG7 2RD, UK.
Jazyk: angličtina
Zdroj: Journal of medical microbiology [J Med Microbiol] 2021 Dec; Vol. 70 (12).
DOI: 10.1099/jmm.0.001462
Abstrakt: Carbapenems are potent members of the β-lactam family that inhibit bacterial cell-wall biosynthesis inhibitors . They are highly effective against Gram-negative and Gram-positive drug-resistant infections . As such, carbapenems are typically reserved as an antibiotic of last resort. The WHO lists meropenem as an essential medicine. Nausea and vomiting are reported in ≤20% of carbapenem recipients, with 1.5% suffering seizures. Enzymatic hydrolysis of the β - lactam ring is the main driver of clinical resistance. These enzymes can be classified as Class A, B and D. Classes A and D are serine β - lactamases, whereas Class B rely on metal-mediated hydrolysis, typically through zinc.
Databáze: MEDLINE